The role of peroxisome proliferator-activated receptors (PPAR) in immune responses

被引：363
|
作者：
Christofides, Anthos [1 ,2 ,3 ]
Konstantinidou, Eirini [1 ,2 ,3 ]
Jani, Chinmay [2 ,4 ]
Boussiotis, Vassiliki A. [1 ,2 ,3 ]
机构：
[1] Harvard Med Sch, Div Hematol Oncol, Boston, MA 02215 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02215 USA
[3] Harvard Med Sch, Ctr Canc, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Mt Auburn Hosp, Dept Med, Cambridge, MA 02138 USA
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 114卷
基金：
美国国家卫生研究院;
关键词：
PPAR; Metabolism; Inflammation; T cells; Myeloid cells; FATTY-ACID OXIDATION; REGULATE MACROPHAGE POLARIZATION; FOAM-CELL-FORMATION; RAT ADIPOSE-TISSUE; DELTA AGONIST; GENE-EXPRESSION; T-CELLS; MESSENGER-RNA; BETA/DELTA ACTIVATION; TRANSCRIPTION FACTOR;
D O I：
10.1016/j.metabol.2020.154338
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Peroxisome proliferator-activated receptors (PPARs) are fatty acid-activated transcription factors of nuclear hormone receptor superfamily that regulate energy metabolism. Currently, three PPAR subtypes have been identified: PPAR alpha, PPAR gamma, and PPAR beta/6. PPAR alpha and PPAR6 are highly expressed in oxidative tissues and regulate genes involved in substrate delivery and oxidative phosphorylation (OXPHOS) and regulation of energy homeostasis. In contrast, PPAR gamma is more important in lipogenesis and lipid synthesis, with highest expression levels in white adipose tissue (WAT). In addition to tissues regulating whole body energy homeostasis, PPARs are expressed in immune cells and have an emerging critical role in immune cell differentiation and fate commitment. In this review, we discuss the actions of PPARs in the function of the innate and the adaptive immune system and their implications in immune-mediated inflammatory conditions. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数：13
相关论文
共 50 条
  • [41] Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPARα and PPARδ
    Smeets, Pascal J. H.
    Teunissen, Birgit E. J.
    Planavila, Anna
    de Vogel-van den Bosch, Heleen
    Willemsen, Peter H. M.
    van der Vusse, Ger J.
    van Bilsen, Marc
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (43) : 29109 - 29118
  • [42] The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases
    Posta, Edit
    Fekete, Istvan
    Varkonyi, Istvan
    Zold, Eva
    Barta, Zsolt
    CELLS, 2024, 13 (20)
  • [43] The role of peroxisome proliferator-activated receptorδ (PPARδ) in the process of implantation in the mink
    Desmarais, J
    Bennett, RD
    Gévry, N
    Murphy, BD
    BIOLOGY OF REPRODUCTION, 2002, 66 : 123 - 123
  • [44] Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
    Gupta, Mrinal
    Mahajan, Vikram K.
    Mehta, Karaninder S.
    Chauhan, Pushpinder S.
    Rawat, Ritu
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2015, 307 (09) : 767 - 780
  • [45] Peroxisome Proliferator-Activated Receptors (PPAR) Agonists as Master Modulators of Tumor Tissue
    Heudobler, Daniel
    Rechenmacher, Michael
    Lueke, Florian
    Vogelhuber, Martin
    Pukrop, Tobias
    Herr, Wolfgang
    Ghibelli, Lina
    Gerner, Christopher
    Reichle, Albrecht
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [46] Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
    Mrinal Gupta
    Vikram K. Mahajan
    Karaninder S. Mehta
    Pushpinder S. Chauhan
    Ritu Rawat
    Archives of Dermatological Research, 2015, 307 : 767 - 780
  • [47] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) - GAMMA IN METABOLIC SYNDROME: FRIENDS OR FOES?
    Vazquez Carrera, M.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2005, 17 : 59 - 69
  • [48] Expression of peroxisome proliferator-activated receptors (PPAR) in human colorectal cancer (CRC)
    Theophilidou, E.
    Neophytou, C.
    Lund, J.
    O'Sullivan, S. E.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 15 - 15
  • [49] An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases
    Changizi, Zahra
    Kajbaf, Forough
    Moslehi, Azam
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (07) : 1542 - 1552
  • [50] The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular Disease
    Nisbet, Rachel E.
    Sutliff, Roy L.
    Hart, C. Michael
    PPAR RESEARCH, 2007, 2007
12345